Reply

Affiliations

¹ Center for Outcomes Research in Liver Disease, Washington, DC; Center for Liver Diseases, Department of Medicine, Inova Fairfax Hospital, Falls Church, Virginia; Inova Medicine, Inova Health System, Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, Virginia.

Comment

Maria Stepanova et al. Clin Gastroenterol Hepatol. 2021 Jun.

. 2021 Jun;19(6):1299-1300.

doi: 10.1016/j.cgh.2020.07.038. Epub 2020 Nov 26.

¹ Center for Outcomes Research in Liver Disease, Washington, DC; Center for Liver Diseases, Department of Medicine, Inova Fairfax Hospital, Falls Church, Virginia; Inova Medicine, Inova Health System, Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, Virginia.

No abstract available

Comment on

Nonalcoholic Steatohepatitis Is the Most Rapidly Increasing Indication for Liver Transplantation in the United States.
Younossi ZM, Stepanova M, Ong J, Trimble G, AlQahtani S, Younossi I, Ahmed A, Racila A, Henry L. Younossi ZM, et al. Clin Gastroenterol Hepatol. 2021 Mar;19(3):580-589.e5. doi: 10.1016/j.cgh.2020.05.064. Epub 2020 Jun 9. Clin Gastroenterol Hepatol. 2021. PMID: 32531342
The Rising Tide of Nonalcoholic Fatty Liver Disease: How Much Time Until the Flood Reaches Our Coast?
Mazzarelli C, Angrisani D, Viganò R. Mazzarelli C, et al. Clin Gastroenterol Hepatol. 2021 Jun;19(6):1299. doi: 10.1016/j.cgh.2020.07.025. Epub 2020 Nov 26. Clin Gastroenterol Hepatol. 2021. PMID: 33248075 No abstract available.